# AnaCardio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/anacardio

- Industry: Biotechnology
- Headquarters: Stockholm, Sweden
- Website: www.anacardio.com
- Total disclosed funding: $104M
- Latest round: Series B (Sep 30, 2026)
- Investors on record: 10

## About

Based in Stockholm, Sweden, and founded in 2017, AnaCardio AB operates as a clinical-stage biopharmaceutical company that develops medicine for the treatment of heart disease. As of September 2022, the company is led by its CEO Patrik Strömberg. In September 2026, AnaCardio AB raised EUR 62.5 million in series B funding co-led by Novo Holdings and Ljungstrom, with participation from Helsinn Healthcare, Pureos Bioventures, Sound Bioventures, Industrifonden, Flerie Invest, LLD Nybohov Invest AB and Innovestor. AnaCardio AB engaged in the development of AC01 for the treatment of heart failure that targets the underlying cause of heart failure: impaired contractility and can be initiated in acute heart failure and transition to chronic oral use. The AC01 drug mimics the peptide and analogously increases contractility ex vivo. The company will use the September 2026 funding to advance AC01 through the Phase 2b GOAL-HF2 trial in chronic HFrEF patients, aiming to achieve Phase 3 readiness by 2028.

## Funding rounds

- Series B, Sep 30, 2026, $71M — Novo Holdings, Industrifonden, Helsinn Healthcare, Innovestor, Flerie Invest, Pureos Bioventures, Sound Bioventures, LLD Nybohov Invest AB
- Series A, Dec 30, 2024, $19M — Novo Holdings, Industrifonden, Flerie Invest, Pureos Bioventures, Sound Bioventures
- Series A, Sep 7, 2022, $14M — Karolinska Development, Industrifonden, 3B Future Health Fund, Flerie Invest
- Seed, Jun 17, 2021, $0.4M — Karolinska Development

## Investors

- Karolinska Development — Seed, Series A
- Industrifonden (https://capitalatlas.ai/funds/industrifonden) — Series A, Series B
- 3B Future Health Fund (https://capitalatlas.ai/funds/3b-future-health-fund) — Series A
- Flerie Invest (https://capitalatlas.ai/funds/flerie-invest) — Series A, Series B
- Novo Holdings — Series A, Series B
- Pureos Bioventures (https://capitalatlas.ai/funds/pureos-bioventures) — Series A, Series B
- Sound Bioventures (https://capitalatlas.ai/funds/sound-bioventures) — Series A, Series B
- Helsinn Healthcare — Series B
- Innovestor (https://capitalatlas.ai/funds/innovestor) — Series B
- LLD Nybohov Invest AB — Series B